Development of D-Limonene Nanoemulsions for Oral Cancer Inhibition: Investigating the Role of Ostwald Ripening Inhibitors and Cell Death Mechanisms
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115279 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Suwisit Manmuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Burapha University, Chon Buri 20131, Thailand. Hauptthemen laut MEDLINE: Limonene, Mouth Neoplasms, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (OPS MHESI), Thailand Science Research and Innovation (TSRI).
Abstract (Originalsprache)
The aim of this study was to investigate the effect of Ostwald ripening inhibitors on D-limonene (D-LMN) nanoemulsions and to elucidate their impact on oral cancer cells. Various inhibitors, including olive oil, soybean oil, and perilla oil, were incorporated into D-LMN nanoemulsions at different ratios (25:75–75:25, D-LMN to inhibitor). The resulting nanoemulsions were evaluated for droplet size, size distribution, zeta potential, stability, droplet morphology, cytotoxicity, antimetastatic and anti-invasive activities, apoptosis induction, and cell cycle arrest. Results showed that the 75:25 D-LMN to inhibitor ratio produced the smallest droplet size and exhibited great stability, particularly with perilla oil. Notably, D-LMN nanoemulsions displayed strong anti-oral cancer effects by reducing cell viability, metastasis, and invasion. Apoptosis was induced, as evidenced by nuclear fragmentation, Annexin V binding, and altered expression of BAX, BCL-XL, Cytochrome c, and Caspase-9. Additionally, the nanoemulsions caused cell cycle arrest via downregulation of Cyclin D1, CDK2, CDK4, and CDK6. These findings highlight the potential of D-LMN nanoemulsions as a promising alternative therapeutic strategy for oral cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Burapha University, Chon Buri 20131, Thailand.
- Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
- Natural Products Research Center, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
ORCID-Profile: Yotsanan Weerapol, Tiraniti Chuenbarn, Sontaya Limmatvapirat, Chutima Limmatvapirat
Förderung
- Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (OPS MHESI), Thailand Science Research and Innovation (TSRI)
Zitieren
APA
Manmuan, S., Weerapol, Y., Chuenbarn, T., Limmatvapirat, S., Limmatvapirat, C., & Tubtimsri, S. (2025). Development of D-Limonene Nanoemulsions for Oral Cancer Inhibition: Investigating the Role of Ostwald Ripening Inhibitors and Cell Death Mechanisms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115279
Vancouver
Manmuan S, Weerapol Y, Chuenbarn T, Limmatvapirat S, Limmatvapirat C, Tubtimsri S. Development of D-Limonene Nanoemulsions for Oral Cancer Inhibition: Investigating the Role of Ostwald Ripening Inhibitors and Cell Death Mechanisms. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115279
BibTeX
@article{Manmuan2025,
author = {Manmuan, Suwisit and Weerapol, Yotsanan and Chuenbarn, Tiraniti and Limmatvapirat, Sontaya and Limmatvapirat, Chutima and Tubtimsri, Sukannika},
title = {Development of D-Limonene Nanoemulsions for Oral Cancer Inhibition: Investigating the Role of Ostwald Ripening Inhibitors and Cell Death Mechanisms},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115279}
}
EUVIMED